JP2022545083A5 - - Google Patents

Info

Publication number
JP2022545083A5
JP2022545083A5 JP2022510980A JP2022510980A JP2022545083A5 JP 2022545083 A5 JP2022545083 A5 JP 2022545083A5 JP 2022510980 A JP2022510980 A JP 2022510980A JP 2022510980 A JP2022510980 A JP 2022510980A JP 2022545083 A5 JP2022545083 A5 JP 2022545083A5
Authority
JP
Japan
Application number
JP2022510980A
Other languages
Japanese (ja)
Other versions
JPWO2021034770A5 (https=
JP2022545083A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2020/046686 external-priority patent/WO2021034770A1/en
Publication of JP2022545083A publication Critical patent/JP2022545083A/ja
Publication of JPWO2021034770A5 publication Critical patent/JPWO2021034770A5/ja
Publication of JP2022545083A5 publication Critical patent/JP2022545083A5/ja
Priority to JP2025028218A priority Critical patent/JP2025074118A/ja
Withdrawn legal-status Critical Current

Links

JP2022510980A 2019-08-20 2020-08-17 パーキンソン病を評価するためのニューロメラニン高感度mri Withdrawn JP2022545083A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2025028218A JP2025074118A (ja) 2019-08-20 2025-02-25 パーキンソン病を評価するためのニューロメラニン高感度mri

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201962889300P 2019-08-20 2019-08-20
US62/889,300 2019-08-20
PCT/US2020/046686 WO2021034770A1 (en) 2019-08-20 2020-08-17 Neuromelanin-sensitive mri for assessing parkinson's disease

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2025028218A Division JP2025074118A (ja) 2019-08-20 2025-02-25 パーキンソン病を評価するためのニューロメラニン高感度mri

Publications (3)

Publication Number Publication Date
JP2022545083A JP2022545083A (ja) 2022-10-25
JPWO2021034770A5 JPWO2021034770A5 (https=) 2023-08-25
JP2022545083A5 true JP2022545083A5 (https=) 2023-08-25

Family

ID=74660631

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2022510980A Withdrawn JP2022545083A (ja) 2019-08-20 2020-08-17 パーキンソン病を評価するためのニューロメラニン高感度mri
JP2025028218A Pending JP2025074118A (ja) 2019-08-20 2025-02-25 パーキンソン病を評価するためのニューロメラニン高感度mri

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2025028218A Pending JP2025074118A (ja) 2019-08-20 2025-02-25 パーキンソン病を評価するためのニューロメラニン高感度mri

Country Status (10)

Country Link
US (2) US20220273184A1 (https=)
EP (1) EP4018202A4 (https=)
JP (2) JP2022545083A (https=)
KR (2) KR20220100851A (https=)
CN (1) CN114787631A (https=)
AU (1) AU2020334980A1 (https=)
CA (1) CA3151632A1 (https=)
IL (1) IL290693A (https=)
MX (1) MX2022002105A (https=)
WO (1) WO2021034770A1 (https=)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10955423B2 (en) 2015-12-15 2021-03-23 The General Hospital Corporation Methods of estimating blood glucose and related systems
US11293852B2 (en) 2016-04-07 2022-04-05 The General Hospital Corporation White blood cell population dynamics
US20220273184A1 (en) * 2019-08-20 2022-09-01 Terran Biosciences, Inc. Neuromelanin-sensitive mri for assessing parkinson's disease
TWI781463B (zh) * 2020-10-15 2022-10-21 臺北醫學大學 腦部多巴胺轉運體檢查系統及其運作方法
JP2024510080A (ja) * 2021-03-11 2024-03-06 テラン バイオサイエンシズ インコーポレイテッド バイオマーカーを含む撮像データセットのハーモナイゼーションのためのシステム、デバイス及び方法
EP4312729A4 (en) * 2021-04-02 2025-02-26 Spintech, Inc. SYSTEMS AND METHODS FOR TEMPLATE-BASED AUTOMATIC RECOGNITION OF ANATOMICAL STRUCTURES
WO2022266654A1 (en) * 2021-06-16 2022-12-22 The General Hospital Corporation Methods to characterize functional and dysfunctional acute inflammatory responses to pathologic processes
US11911170B2 (en) * 2021-09-13 2024-02-27 Christopher J. Rourk Deep brain sensing and stimulation probe
TW202333668A (zh) 2021-12-15 2023-09-01 美商德利克斯醫療公司 經苯氧基及苄氧基取代之精神成形素(psychoplastogen)及其用途
WO2023235766A2 (en) * 2022-05-31 2023-12-07 University Of Ottawa Institute Of Mental Health Research Methods for acquiring and analyzing neuromelanin-sensitive mri
US12599313B2 (en) * 2022-06-23 2026-04-14 ViBo Health LLC Health trackers for autonomous targeting of tissue sampling sites
CN114999657A (zh) * 2022-08-03 2022-09-02 首都医科大学附属北京友谊医院 评估帕金森病患者的神经纤维束与步态障碍的相关性的方法和相关产品
US20260049105A1 (en) * 2022-08-18 2026-02-19 Arizona Board Of Regents On Behalf Of The University Of Arizona Selective mc4r ligand for treating obesity and cognitive loss
WO2024081800A1 (en) * 2022-10-12 2024-04-18 Octave Bioscience, Inc. Measuring brain volumes for modeling neurological disease state
CN115735857B (zh) * 2022-11-24 2025-11-18 江苏珂玛麒生物科技有限公司 一种帕金森病动物模型的构建方法
KR102906269B1 (ko) * 2023-08-03 2026-01-02 재단법인대구경북과학기술원 파킨슨 환자의 lid 발병 예측을 위한 정보제공방법
CN116740064B (zh) * 2023-08-14 2023-10-20 山东奥洛瑞医疗科技有限公司 一种核磁共振肿瘤区域提取方法
CN117372437B (zh) * 2023-12-08 2024-02-23 安徽农业大学 用于面神经麻痹智能化检测与量化方法及其系统
KR102832391B1 (ko) * 2024-08-13 2025-07-14 주식회사 휴런 Mri영상에서 뉴로멜라닌의 탈침착 정량화를 위한 이미지 처리방법 및 그 처리장치
KR102834035B1 (ko) * 2024-08-16 2025-07-21 주식회사 휴런 3d 멀티 에코 gre를 이용한 뉴로멜라닌과 나이그로좀1의 동시 촬영 및 이미지 처리방법

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6288545B1 (en) * 1999-03-22 2001-09-11 General Electric Company Method and apparatus for calibration of RF and gradient field time delays
EP1332363A4 (en) * 2000-10-09 2007-08-29 Kay Double PROOF OF NEURODEGENERATIVE DISEASES
US20070275944A1 (en) * 2006-04-05 2007-11-29 The Board Of Trustees Operating Michigan State University Antioxidants and methods of their use
EP2844143B1 (en) * 2012-05-04 2023-07-19 Emory University Method for imaging and determining information associated with regions of the brain
US9600778B2 (en) * 2013-07-02 2017-03-21 Surgical Information Sciences, Inc. Method for a brain region location and shape prediction
US20150023877A1 (en) * 2013-07-18 2015-01-22 The Board Of Trustees Of The Leland Stanford Junior University Methods of parkinsons disease diagnosis and monitoring treatment
ES2822201T3 (es) * 2014-06-12 2021-04-29 Commissariat Energie Atomique Método de IRM para cuantificar la cantidad de hierro en tejidos utilizando difusión por imágenes de resonancia magnética
WO2016154682A1 (en) * 2015-04-02 2016-10-06 Crc For Mental Health Ltd Method for predicting risk of cognitive deterioration
US11352671B2 (en) * 2015-05-01 2022-06-07 Vanderbilt University Predicting therapeutic response in Parkinson's disease
WO2017053718A2 (en) * 2015-09-23 2017-03-30 Boston Medical Center Corporation Biomarkers for the early detection of parkinson's disease
EP3547252B1 (en) * 2016-12-28 2025-10-22 Shanghai United Imaging Healthcare Co., Ltd. Multi-modal image processing system and method
CN113271985A (zh) * 2018-08-07 2021-08-17 悦智有限公司 用于诊断多巴胺能和运动障碍的方法
US20220273184A1 (en) * 2019-08-20 2022-09-01 Terran Biosciences, Inc. Neuromelanin-sensitive mri for assessing parkinson's disease

Similar Documents

Publication Publication Date Title
BR112023005462A2 (https=)
JP2022545083A5 (https=)
BR112023012656A2 (https=)
BR112021014123A2 (https=)
BR112023009656A2 (https=)
BR112022009896A2 (https=)
BR112021017747A2 (https=)
BR112022024743A2 (https=)
BR112022026905A2 (https=)
BR112023011738A2 (https=)
BR112023004146A2 (https=)
BR112023006729A2 (https=)
BR102021018859A2 (https=)
BR102021015500A2 (https=)
BR112023016292A2 (https=)
BR112023011610A2 (https=)
BR112023011539A2 (https=)
BR112023008976A2 (https=)
BR102021020147A2 (https=)
BR102021018926A2 (https=)
BR102021018167A2 (https=)
BR102021017576A2 (https=)
BR102021016837A2 (https=)
BR102021016551A2 (https=)
BR102021016375A2 (https=)